Opioid Addiction Risk Transparency Act
Do you support it?
Want to know if it passes?
We'll email you when S 1049 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on S 1049.
You're tracking S 1049
We'll email you the moment it moves.
S 1049 — Opioid Addiction Risk Transparency Act
Last action — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 115th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Opioid Addiction Risk Transparency Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.
Bill Text
- Introduced Introduced in Senate Current html May 04, 2017
Compared against current U.S. Code AI-generated reading aid — verify against the official bill.
The bill adds requirements for communication plans in risk evaluation and mitigation strategies for certain drugs under the Federal Food, Drug, and Cosmetic Act.
-
21 U.S.C. 355-1(e)(3)
(D) disseminating information to health care providers about the meaning of terms related to drug formulations or properties that are described in the drug labeling, including information about the limitations or patient care implications of such formulations or properties, and how such formulations or properties may be related to serious adverse drug events associated with use of the drug.
This change requires the dissemination of specific information related to drug formulations and properties to healthcare providers.
Action History
-
Introduced in Senate
-
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
- Margaret Wood Hassan · Primary
- Todd Young · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 1 co-sponsors · 545 not signed on
Sponsors (1)
- Hassan, Margaret Wood Democratic
Co-sponsors (1)
- Young, Todd Republican
Not signed on (545)
545 members have not signed on to this bill.
Show all 545 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does S 1049 do?
- Opioid Addiction Risk Transparency Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.
- Who sponsors S 1049?
- S 1049 is sponsored by Hassan, Margaret Wood (Democratic) and Young, Todd (Republican).
- What is the current status of S 1049?
- This bill died with 115th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track S 1049?
- Track S 1049 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S 1049
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S 1049
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →